GLUT4 associated proteins as therapeutic targets for diabetes

Recent Patents on Endocrine, Metabolic and Immune Drug Discovery

Volumn 5, Issue 1, 2011, Pages 25-32

  Morgan, Broden J ^a   Chai, Siew Yeen ^a   Albiston, Anthony L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

AS160; FHOS; GLUT4; Insulin; IRAP; Myostatin; NIDDM; PI3K

Indexed keywords

FATTY ACID; GLUCOSE TRANSPORTER 4; GLYCOPROTEIN; GUANOSINE TRIPHOSPHATASE; INSULIN; MYOSTATIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN AS 160; PROTEIN IRAP; UNCLASSIFIED DRUG;

ADIPOCYTE; ARTICLE; CELL MEMBRANE; CELL MIGRATION; CELL SURFACE; CYTOPLASM; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION;

CYSTINYL AMINOPEPTIDASE; DIABETES MELLITUS, TYPE 2; DRUGS, INVESTIGATIONAL; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; HUMANS; MOLECULAR TARGETED THERAPY; PATENTS AS TOPIC; PROTEIN TRANSPORT;

EID: 79551644805     PISSN: 18722148     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221411794351914     Document Type: Article

References (81)

1. McKeigue PM, Marmot MG, Court YDS, Cottier DE, Rahman S, Riemersma RA. Diabetes, hyperinsulinemia, and coronary riskfactors in Bangladeshis in East London. Br Heart J 1988; 60(5): 390-6.
2. Orahilly S. Science, medicine, and the future - Non-insulin dependent diabetes mellitus: The gathering storm. Br Heart J 1997; 314(7085): 955-9.
3. Massague J, Pilch PF, Czech MP. Electrophoretic resolution of 3 major insulin-receptor structures with unique subunit stoichiometries. Proc Natl Acad Sci USA 1980; 77(12): 7137-41.
4. Massague J, Pilch PF, Czech MP. A unique proteolytic cleavage site on the beta-subunit of the insulin-receptor. J Biol Chem 1981; 256(7): 3182-90.
5. Czech MP, Massague J, Pilch PF. The insulin receptor - structural features. Trends Biochem Sci 1981; 6(8): 222-5.
6. Hedo JA, Kasuga M, Vanobberghen E, Roth J, Kahn CR. Direct demonstration of glycosylation of insulin-receptor subunits by biosynthetic and external labeling - evidence for heterogeneity. Proc Natl Acad Sci USA 1981; 78(8): 4791-5.
7. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzzelli LM, Dull TJ, et al. Human insulin-receptor and it's relationship to the tyrosine kinase family of oncogenes. Nature 1985; 313(6005): 756-61.
8. Rothman DL, Shulman RG, Shulman GI. P-31 nuclear-magneticresonance measurements of muscle glucose-6-phosphate - evidence for reduced insulin-dependent muscle glucose-transport or phosphorylation activity in non-insulin-dependent diabetesmellitus. J Clin Invest 1992; 89(4): 1069-75.
9. Yang YJ, Hope ID, Ader M, Bergman RN. Insulin tranport across capillaries is rate limiting for insulin action in dogs. J Clin Invest 1989; 84(5): 1620-8.
10. Watson RT, Pessin JE. Bridging the GAP between insulin signaling and GLUT4 translocation. Trends Biochem Sci 2006; 31(4): 215-22.
11. Shia MA, Pilch PF. The beta-subunit of the insulin-receptor is an insulin-activated protein-kinase. Biochemistry 1983; 22(4): 717-21.
12. Kasuga M, Karlsson FA, Kahn CR. Insulin stimulates the phosphorylation of the 95,000-Daltan subunit of its own receptor. Science 1982; 215(4529): 185-7.
13. White MF, Livingston JN, Backer JM, Lauris V, Dull TJ, Ullrich A, et al. Mutation of the insulin-receptor at tyrosine-960 inhibits signal transmission but does not affect its tyrosine kinase-activity. Cell 1988; 54(5): 641-9.
14. Stadtmauer LA, Rosen OM. Phosphorylation of exogenous substrates by the insulin-receptor associated protein-kinase. J Biol Chem 1983; 258(11): 6682-5.
15. Thong FSL, Dugani CB, Klip A. Turning signals on and off: GLUT4 traffic in the insulin-signaling highway. Physiology 2005; 20: 271-84.
16. Peck GR, Ye SY, Pham V, Fernando RN, Macaulay SL, Chai SY, et al. Interaction of the Akt substrate, AS160, with the glucose transporter 4 vesicle marker protein, insulin-regulated aminopeptidase. Mol Endocrinol 2006; 20(10): 2576-83.
17. Pattaranit R, Van Den Berg HA. The development of insulin resistance in Type 2 diabetes: Insights from knockout studies. Sci Prog 2008; 91(3): 285-316.
18. Wang C. The D-glucose transporter is tissue-specific - skeletalmuscle and adipose-tissue have a unique form of glucose transporter. J Biol Chem 1987; 262(32): 15689-95.
19. Charron MJ, Brosius FC, Alper SL, Lodish HF. A glucosetransport protein expressed predominantly in insulin-responsive tissues. Proc Natl Acad Sci USA 1989; 86(8): 2535-9.
20. Mueckler M. Facilitative glucose transporters. Eur J Biochem 1994; 219(3): 713-25.
21. James DE, Strube M, Mueckler M. Molecular-cloning and characterization of an insulin-regulatable glucose transporter. Nature 1989; 338(6210): 83-7.
22. Kim JK, Zisman A, Fillmore JJ, Peroni OD, Kotani K, Perret P, et al. Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. J Clin Invest 2001; 108(1): 153-60.
23. Stenbit AE, Tsao TS, Li J, Burcelin R, Geenen DL, Factor SM, et al. GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat Med 1997; 3(10): 1096-101.
24. Tsao TS, Burcelin R, Katz EB, Huang L, Charron MJ. Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 1996; 45(1): 28-36.
25. Haspel HC, Rosenfeld MG, Rosen OM. Charecterization of antisera to a synthetic carboxyl-terminal peptide of the glucose transporter protein. J Biol Chem 1988; 263(1): 398-403.
26. Martin S, Tellam J, Livingstone C, Slot JW, Gould GW, James DE. The glucose transporter (GLUT-4) and vesicle-associated membrane protein-2 (VAMP-2) are segregated from recycling endosomes in insulin-sensitive cells. J Cell Biol 1996; 134(3): 625-35.
27. Slot JW, Geuze HJ, Gigengack S, Lienhard GE, James DE. Immuno-localization of the insulin regulatable glucose transporter in brown adipose-tissue of the rat. J Cell Biol 1991; 113(1): 123-35.
28. Martin LB, Shewan A, Millar CA, Gould GW, James DE. Vesicleassociated membrane protein 2 plays a specific role in the insulindependent trafficking of the facilitative glucose transporter GLUT4 in 3T3-L1 adipocytes. J Biol Chem 1998; 273(3): 1444-52.
29. Ramm G, Slot JW, James DE, Stoorvogel W. Insulin recruits GLUT4 from specialized VAMP2-carrying vesicles as well as from the dynamic endosomal/trans-golgi network in rat adipocytes. Mol Biol Cell 2000; 11(12): 4079-91.
30. Govers R, Coster ACF, James DE. Insulin increases cell surface GLUT4 levels by dose dependently discharging GLUT4 into a cell surface recycling pathway. Mol Cell Biol 2004; 24(14): 6456-66.
31. Karylowski O, Zeigerer A, Cohen A, McGraw TE. GLUT4 is retained by an intracellular cycle of vesicle formation and fusion with endosomes. Mol Biol Cell 2004; 15(2): 870-82.
32. Martin S, Rice JE, Gould GW, Keller SR, Slot JW, James DE. The glucose transporter GLUT4 and the aminopeptidase vp165 colocalise in tubulo-vesicular elements in adipocytes and cardiomyocytes. J Cell Sci 1997; 110: 2281-91.
33. Cain CC, Trimble WS, Lienhard GE. Members of the VAMP family of synaptic vesicle proteins are components of glucose transporter-containing vesicles from rat adipocytes. J Biol Chem 1992; 267(17): 11681-4.
34. Lin BZ, Pilch PF, Kandror KV. Sortilin is a major protein component of GLUT4-containing vesicles. J Biol Chem 1997; 272(39): 24145-7.
35. Kandror KV, Yu LC, Pilch PF. The major protein of GLUT4- containing vesicles, GP160, has aminopeptidase activity. J Biol Chem 1994; 269(49): 30777-80.
36. Mastick CC, Aebersold R, Lienhard GE. Characterization of a major protein in GLUT4 vesicles - concentration in the vesicles and insulin-stimulated translocation to the plasma-membrane. J Biol Chem1994; 269(8): 6089-92.
37. Keller SR, Scott HM, Mastick CC, Aebersold R, Lienhard GE. Cloning and characterization of a novel insulin-regulated aminopeptidase from GLUT4 vesicles. J Biol Chem 1995; 270(40): 23612-8.
38. Kandror K, Pilch PF. Identification and isolation of glycoproteins that translocate to the cell-surface from GLUT4-enriched vesicles in an insulin-dependent fashion. J Biol Chem 1994; 269(1): 138-42.
39. Laustsen PG, Rasmussen TE, Petersen K, PedrazaDiaz S, Moestrup SK, Gliemann J, et al. The complete amino acid sequence of human placental oxytocinase. Biochim Biophys Acta 1997; 1352(1): 1-7.
40. Rogi T, Tsujimoto M, Nakazato H, Mizutani S, Tomoda Y. Human placental leucine aminopeptidase/oxytocinase. A new member of type II membrane-spanning zinc metallopeptidase family. J Biol Chem 1996; 271(1): 56-61.
41. Albiston AL, McDowall SG, Matsacos D, Sim P, Clune E, Mustafa T, et al. Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin regulated aminopeptidase. J Biol Chem 2001; 276: 48263-6.
42. Albiston AL, Peck GR, Yeatman HR, Fernando R, Ye S, Chai SY. Therapeutic targeting of insulin-regulated aminopeptidase: Heads and tails? Pharmacol Ther 2007; 116(3): 417-27.
43. Kandror KV, Pilch PF. GP160, a tissue-specific marker for insulinactivated glucose-transport. Proc Natl Acad Sci USA 1994; 91(17): 8017-21.
44. Ross SA, Scott HM, Morris NJ, Leung WY, Mao F, Lienhard GE, et al. Characterization of the insulin-regulated membrane aminopeptidase in 3T3-L1 adipocytes. J Biol Chem 1996; 271(6): 3328-32.
45. Johnson AO, Lampson MA, McGraw TE. A di-leucine sequence and a cluster of acidic amino acids are required for dynamic, retention in the endosomal recycling compartment of fibroblasts. Mol Biol Cell 2001; 12(2): 367-81.
46. Waters SB, Dauria M, Martin SS, Nguyen C, Kozma LM, Luskey KL. The amino terminus of insulin-responsive aminopeptidase causes Glut4 translocation in 3T3-L1 adipocytes. J Biol Chem 1997; 272(37): 23323-7.
47. Hosaka T, Brooks CC, Presman E, Kim SK, Zhang ZD, Breen M, et al. p115 interacts with the GLUT4 vesicle protein, IRAP, and plays a critical role in insulin-stimulated GLUT4 translocation. Mol Biol Cell 2005; 16(6): 2882-90.
48. Tojo H, Kaieda I, Hattori H, Katayama N, Yoshimura K, Kakimoto S, et al. The formin family protein, formin homolog overexpressed in spleen, interacts with the insulin-responsive aminopeptidase and profilin IIa. Mol Endocrinol 2003; 17(7): 1216-29.
49. Katagiri H, Asano T, Yamada T, Aoyama T, Fukushima Y, Kikuchi M, et al. Acyl-Coenzyme A dehydrogenases are localized on GLUT4-containing vesicles via association with insulinregulated aminopeptidase in a manner dependent on its dileucine motif. Mol Endocrinol 2002; 16(5): 1049-59.
50. Kane S, Sano H, Liu SCH, Asara JM, Lane WS, Garner CC, et al. A method to identify serine kinase substrates - Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J Biol Chem 2002; 277(25): 22115-8.
51. Zeigerer A, McBrayer MK, McGraw TE. Insulin stimulation of GLUT4 exocytosis, but not its inhibition of endocytosis, is dependent on RabGAP AS160. Mol Biol Cell 2004; 15(10): 4406-15.
52. Larance M, Ramm G, Stockli J, van Dam EM, Winata S, Wasinger V, et al. Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking. J Biol Chem 2005; 280(45): 37803-13.
53. Sano H, Kane S, Sano E, Miinea CP, Asara JM, Lane WS, et al. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem 2003; 278(17): 14599-602.
54. Chi NW, Lodish HF. Tankyrase is a Golgi-associated mitogenactivated protein kinase substrate that interacts with IRAP in GLUT4 vesicles. J Biol Chem 2000; 275(49): 38437-44.
55. Sbodio JI, Chi NW. Identification of a tankyrase-binding motif shared by IRAP, TAB182, and human TRF1 but not mouse TRF1 - NuMA contains this RXXPDG motif and is a novel tankyrase partner. J Biol Chem 2002; 277(35): 31887-92.
56. Yeh TYJ, Sbodio JI, Tsun ZY, Luo B, Chi NW. Insulin-stimulated exocytosis of GLUT4 is enhanced by IRAP and its partner tankyrase. Biochem J 2007; 402: 279-90.
57. Bogan, J.S., Lodish, H.F. Method of measuring plasma membrane targeting of GLUT4. US20020052012 (2002).
58. Fletcher, L.M., Tavare, J.M. Assay. US20030104490 (2003).
59. Bogan JS, McKee AE, Lodish HF. Insulin-responsive compartments containing GLUT4 in 3T3-L1 and CHO Cells: Regulation by amino acid concentrations. Mol Cell Biol 2001; 21(14): 4785-806.
60. Bogan, J.S., Lodish, H.F. Expression cloning method. US20020155479 (2002).
61. Bogan JS, Hendon N, McKee AE, Tsao TS, Lodish HF. Functional cloning of TUG as a regulator of GLUT4 glucose transporter trafficking. Nature 2003; 425(6959): 727-33.
62. Tojo, H., Katayama, N., Kakimoto, S. IRAP-binding protein. US20040086510 (2004).
63. Tojo, H., Katayama, N., Kakimoto, S. Novel gene and use thereof. US20060183158 (2006).
64. Lienhard, G.E., Kane, S., Minnea, C.P., Sano, H. Method for identifying agents which modulate Gtpase activity involved in insulin-stimulated GLUT4 translocation. US2006099005 (2006) & US7799538 (2010).
65. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387(6628): 83-90.
66. Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 2001; 98(16): 9306-11.
67. Strassmann, G., Liang, L.-F., Topouzis, S. Methods for treating diabetes. US20090035297 (2009).
68. Gunton, J. Kahn, R. C. Methods of treating diabetes US7700555 (2010).
69. Wolff, A., Jerling, M. Method of treating diabetes. US20100197701 (2010).
70. Aghajanian, J., Dunham, W.J., Wolfman, N.M., O'Hara, D., Davies, M.V., Veldman, G.M., Bridges, K.G., Whittemore, L.-A., Khurana, T.S., Bouxsein, M.L. Antibody inhibitors of GDF-8 and uses thereof. US20030138422 (2003).
71. Antony N, Bass JJ, McMahon CD, Mitchell MD. Myostatin regulates glucose uptake in BeWo cells. Am J Physiol-Endocrinol Metab 2007; 293(5): E1296-E302.
72. Morissette MR, Cook SA, Foo S, McKoy G, Ashida N, Novikov M, et al. Myostatin regulates cardiomyocyte growth through modulation of Akt signaling. Circ Res 2006; 99(1): 15-24.
73. Merrill GF, Kurth EJ, Hardie DG, Winder WW. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol-Endocrinol Metab 1997; 36(6): E1107-E12.
74. Thong FSL, Bilan PJ, Klip A. The Rab GTPase-activating protein AS160 Integrates Akt, protein kinase C, and AMP-activated protein kinase signals regulating GLUT4 traffic. Diabetes 2007; 56(2): 414-23.
75. Winder, W.W. Use of AMP kinase activators for treatment type 2 diabetes and insulin resistance. US20030212013 (2003).
76. Saez, E., Tontonoz, P., Laffitte, B.A., Li, J. Novel use of liver X receptor agonists. US20050036992 (2005).
77. Husson, B., Broqua, P., Junien, J.-l. Novel use of liver X receptor agonists. US20090118306 (2009).
78. Edwards PA, Kast HR, Anisfeld AM. BAREing it all: The Adoption of LXR and FXR and their roles in lipid homeostasis. J Lipid Res 2002; 43(1): 2-12.
79. Guha, M., Kabakibi, A. Methods for the upregulation of GLUT4 via modulation of PPAR delta in adipose tissue and for the treatment of disease. US20070249519 (2007).
80. Dey, D., Mandal, S.K., Mukherjee, M., Pal, B.C., Biswas, T., Datta, M., Roy, S.S., Bandyopadhyay, A., Bhattacharya, S., Giri, B.B., Bandopadhyay, S., Konar, A. Herbal extract and compound lupinoside and its analogues as anti-diabetic type ii drugs from plant Pueraria tuberosa. US20050153000 (2005).
81. Dey D, Pal BC, Biswas T, Roy SS, Bandyopadhyay A, Mandal SK, et al. A Lupinoside prevented fatty acid induced inhibition of insulin sensitivity in 3T3 L1 adipocytes. Mol Cell Biochem 2007; 300(1-2): 149-57.